<?xml version="1.0" encoding="UTF-8"?>
<results title="disease">
 <result pre="Context1745-19811740-4398BioExcel Publishing Ltd pmcid: 7328712 doi: 10.7573/dic.2020-4-15dic-2020-4-15 : Review Coronavirus" exact="disease" post="2019 (COVID-19): latest developments in potential treatments HonKam LunMBBS,"/>
 <result pre="manner specified below. No commercial use without permission. Abstract Many" exact="viral" post="respiratory infections can cause severe acute respiratory symptoms leading"/>
 <result pre="specified below. No commercial use without permission. Abstract Many viral" exact="respiratory" post="infections can cause severe acute respiratory symptoms leading to"/>
 <result pre="below. No commercial use without permission. Abstract Many viral respiratory" exact="infections" post="can cause severe acute respiratory symptoms leading to mortality"/>
 <result pre="without permission. Abstract Many viral respiratory infections can cause severe" exact="acute" post="respiratory symptoms leading to mortality and morbidity. In the"/>
 <result pre="permission. Abstract Many viral respiratory infections can cause severe acute" exact="respiratory" post="symptoms leading to mortality and morbidity. In the spring"/>
 <result pre="mortality and morbidity. In the spring of 2003, the severe" exact="acute" post="respiratory syndrome (SARS) outbreak caused by SARS-CoV spread globally."/>
 <result pre="and morbidity. In the spring of 2003, the severe acute" exact="respiratory" post="syndrome (SARS) outbreak caused by SARS-CoV spread globally. In"/>
 <result pre="morbidity. In the spring of 2003, the severe acute respiratory" exact="syndrome" post="(SARS) outbreak caused by SARS-CoV spread globally. In the"/>
 <result pre="spread globally. In the summer of 2012, the Middle East" exact="respiratory" post="syndrome (MERS) outbreak caused by MERS-CoV occurred in Saudi"/>
 <result pre="globally. In the summer of 2012, the Middle East respiratory" exact="syndrome" post="(MERS) outbreak caused by MERS-CoV occurred in Saudi Arabia."/>
 <result pre="in Saudi Arabia. In the winter of 2019, the coronavirus" exact="disease" post="2019 (COVID-19) outbreak caused by a novel coronavirus SARS-CoV-2"/>
 <result pre="thus far have not been promising. COVID-19 causes a mild" exact="respiratory" post="disease in the majority of cases, but in some"/>
 <result pre="far have not been promising. COVID-19 causes a mild respiratory" exact="disease" post="in the majority of cases, but in some cases,"/>
 <result pre="cases, but in some cases, cytokine activation causes sepsis and" exact="acute" post="respiratory distress syndrome, leading to morbidity and mortality. Immunomodulatory"/>
 <result pre="but in some cases, cytokine activation causes sepsis and acute" exact="respiratory" post="distress syndrome, leading to morbidity and mortality. Immunomodulatory treatments"/>
 <result pre="catch-up all along. coronavirus COVID-19 review SARS-CoV-2 therapeutics vaccines Introduction" exact="Viral" post="respiratory infections such as influenza and measles, which can"/>
 <result pre="all along. coronavirus COVID-19 review SARS-CoV-2 therapeutics vaccines Introduction Viral" exact="respiratory" post="infections such as influenza and measles, which can cause"/>
 <result pre="along. coronavirus COVID-19 review SARS-CoV-2 therapeutics vaccines Introduction Viral respiratory" exact="infections" post="such as influenza and measles, which can cause severe"/>
 <result pre="infections such as influenza and measles, which can cause severe" exact="acute" post="respiratory symptoms, have been responsible for many epidemics. In"/>
 <result pre="such as influenza and measles, which can cause severe acute" exact="respiratory" post="symptoms, have been responsible for many epidemics. In the"/>
 <result pre="epidemics. In the spring of 2003, an outbreak of severe" exact="acute" post="respiratory infection (SARI) spread globally.1,2,3 The World Health Organization"/>
 <result pre="In the spring of 2003, an outbreak of severe acute" exact="respiratory" post="infection (SARI) spread globally.1,2,3 The World Health Organization (WHO)"/>
 <result pre="the spring of 2003, an outbreak of severe acute respiratory" exact="infection" post="(SARI) spread globally.1,2,3 The World Health Organization (WHO) coined"/>
 <result pre="The World Health Organization (WHO) coined the acronym SARS (severe" exact="acute" post="respiratory syndrome) for this SARI and subsequently named the"/>
 <result pre="World Health Organization (WHO) coined the acronym SARS (severe acute" exact="respiratory" post="syndrome) for this SARI and subsequently named the causative"/>
 <result pre="be caused by a new coronavirus. The WHO named this" exact="respiratory" post="disease Middle East respiratory syndrome also known by the"/>
 <result pre="caused by a new coronavirus. The WHO named this respiratory" exact="disease" post="Middle East respiratory syndrome also known by the acronym"/>
 <result pre="new coronavirus. The WHO named this respiratory disease Middle East" exact="respiratory" post="syndrome also known by the acronym MERS and called"/>
 <result pre="coronavirus. The WHO named this respiratory disease Middle East respiratory" exact="syndrome" post="also known by the acronym MERS and called the"/>
 <result pre="named as SARS-CoV-2 due to similarities to SARS-CoV, and the" exact="disease" post="was called coronavirus disease 2019 (COVID-19). SARS-CoV-2 is a"/>
 <result pre="to similarities to SARS-CoV, and the disease was called coronavirus" exact="disease" post="2019 (COVID-19). SARS-CoV-2 is a newly emergent coronavirus closely"/>
 <result pre="coronavirus closely related to SARS and MERS.4 COVID-19 is a" exact="respiratory" post="tract infection that causes mild symptoms in the majority"/>
 <result pre="related to SARS and MERS.4 COVID-19 is a respiratory tract" exact="infection" post="that causes mild symptoms in the majority of cases,"/>
 <result pre="outcomes in the older population, immunocompromised patients, and those with" exact="chronic" post="cardiovascular or respiratory conditions.4 At present, no pharmaceutical products"/>
 <result pre="in the older population, immunocompromised patients, and those with chronic" exact="cardiovascular" post="or respiratory conditions.4 At present, no pharmaceutical products have"/>
 <result pre="older population, immunocompromised patients, and those with chronic cardiovascular or" exact="respiratory" post="conditions.4 At present, no pharmaceutical products have been shown"/>
 <result pre="groups around the world are actively developing treatments against this" exact="disease" post="to reduce morbidities and mortalities. In the long term,"/>
 <result pre="the goal is to develop a vaccine to prevent further" exact="infections" post="and future outbreaks. However, an effective vaccine may take"/>
 <result pre="11 systematic reviews. The discussion is based on, but not" exact="limited" post="to, these search results. Overview of the history of"/>
 <result pre="of the history of treatments for coronavirus outbreaks SARS 2003" exact="Severe" post="acute respiratory syndrome is a viral respiratory disease of"/>
 <result pre="the history of treatments for coronavirus outbreaks SARS 2003 Severe" exact="acute" post="respiratory syndrome is a viral respiratory disease of zoonotic"/>
 <result pre="history of treatments for coronavirus outbreaks SARS 2003 Severe acute" exact="respiratory" post="syndrome is a viral respiratory disease of zoonotic origin"/>
 <result pre="of treatments for coronavirus outbreaks SARS 2003 Severe acute respiratory" exact="syndrome" post="is a viral respiratory disease of zoonotic origin caused"/>
 <result pre="coronavirus outbreaks SARS 2003 Severe acute respiratory syndrome is a" exact="viral" post="respiratory disease of zoonotic origin caused by SARS-CoV. The"/>
 <result pre="outbreaks SARS 2003 Severe acute respiratory syndrome is a viral" exact="respiratory" post="disease of zoonotic origin caused by SARS-CoV. The SARS"/>
 <result pre="SARS 2003 Severe acute respiratory syndrome is a viral respiratory" exact="disease" post="of zoonotic origin caused by SARS-CoV. The SARS outbreak"/>
 <result pre="effective antiviral agents. The use of broad-spectrum antibiotics to treat" exact="secondary" post="bacterial infections was the main treatment regimen.9 Ribavirin, a"/>
 <result pre="antiviral agents. The use of broad-spectrum antibiotics to treat secondary" exact="bacterial infections" post="was the main treatment regimen.9 Ribavirin, a broad-spectrum purine"/>
 <result pre="agents. The use of broad-spectrum antibiotics to treat secondary bacterial" exact="infections" post="was the main treatment regimen.9 Ribavirin, a broad-spectrum purine"/>
 <result pre="analogue, was empirically used as a broad-spectrum antiviral agent.10 Human" exact="immunodeficiency" post="virus (HIV) protease inhibitor lopinavir/ritonavir were also used, as"/>
 <result pre="no effective vaccine has since emerged. MERS 2012 Middle East" exact="respiratory" post="syndrome caused by MERS-CoV may have been transmitted to"/>
 <result pre="effective vaccine has since emerged. MERS 2012 Middle East respiratory" exact="syndrome" post="caused by MERS-CoV may have been transmitted to humans"/>
 <result pre="optimal treatment strategy for MERS-CoV infection.15 The MIRACLE trial (MERS-CoV" exact="Infection" post="tReated with A Combination of Lopinavir/ritonavir and intErferon-Î²1b) was"/>
 <result pre="originated in bats and transmitted to humans via an unknown" exact="intermediate" post="host, possibly pangolins.20,21 SARS-CoV-2 first emerged in Wuhan, Hubei"/>
 <result pre="Hubei Province, China in December 2019, after a cluster of" exact="pneumonia" post="cases with unknown causes was reported. The COVID-19 outbreak"/>
 <result pre="in Wuhan quickly spread around the world within a very" exact="short" post="period of time. There are 5.5 million confirmed cases"/>
 <result pre="(IL)-2, IL-7, IL-10, granulocyte-colony stimulating factor, interferon-Î³ inducible protein 10," exact="monocyte" post="chemoattractant protein 1, macrophage inflammatory protein 1-Î±, and tumour"/>
 <result pre="the lungs of patients with COVID-19 revealed immunopathological changes including" exact="diffuse" post="alveolar damage, desquamation of pneumocytes, pulmonary oedema, hyaline membrane"/>
 <result pre="revealed immunopathological changes including diffuse alveolar damage, desquamation of pneumocytes," exact="pulmonary" post="oedema, hyaline membrane formation, and interstitial mononuclear inflammatory infiltrates.26"/>
 <result pre="membrane formation, and interstitial mononuclear inflammatory infiltrates.26 According to the" exact="limited" post="number of reports of biopsy/autopsy results of patients with"/>
 <result pre="SARS.3,12,19,29â€&quot;,32 An important strategy would be to possibly control the" exact="viral" post="replication using an effective antiviral agent to minimise the"/>
 <result pre="minimise the subsequent inflammation and tissue damage due to high" exact="viral" post="loads. Immunomodulators could play a rescue therapy role, as"/>
 <result pre="need for hospitalisation.36 According to the Report by the WHO-China" exact="Joint" post="Mission on Coronavirus Disease 2019 (COVID-19), out of 55,924"/>
 <result pre="to the Report by the WHO-China Joint Mission on Coronavirus" exact="Disease" post="2019 (COVID-19), out of 55,924 patients in China with"/>
 <result pre="with laboratory-confirmed COVID-19, only 13.8% had severe symptoms including dyspnoea," exact="respiratory" post="frequency â‰¥30/minute, blood oxygen saturation â‰¤93%, PaO2/FiO2 ratio &amp;lt;300,"/>
 <result pre="lung field within 24â€&quot;48 hours; whereas, 6.1% were critical including" exact="respiratory" post="failure, septic shock, and multiple organ dysfunction/failure.37 At present,"/>
 <result pre="within 24â€&quot;48 hours; whereas, 6.1% were critical including respiratory failure," exact="septic shock," post="and multiple organ dysfunction/failure.37 At present, there is no"/>
 <result pre="extracorporeal membrane oxygenation.40 In addition to the standard management for" exact="acute" post="respiratory distress syndrome, the literature also suggests lower intubation"/>
 <result pre="membrane oxygenation.40 In addition to the standard management for acute" exact="respiratory" post="distress syndrome, the literature also suggests lower intubation threshold,"/>
 <result pre="management for acute respiratory distress syndrome, the literature also suggests" exact="lower" post="intubation threshold, early prone positioning, and cautious fluid status"/>
 <result pre="Remdesivir Remdesivir (GS-5734) is a nucleoside analogue prodrug that inhibits" exact="viral" post="RNA polymerases, and was developed by Gilead Science in"/>
 <result pre="during follow-up.42 Subsequently, a double-blinded randomised controlled trial in 237" exact="adult" post="patients with severe COVID-19 showed that remdesivir was not"/>
 <result pre="adverse events, and nearly 14% of the recipients could not" exact="complete" post="the full 14-day course of treatment.54 Other adverse effects"/>
 <result pre="limit the dosage needed, as the concentration necessary to inhibit" exact="viral" post="replication is relatively high.54 Other clinical trials have been"/>
 <result pre="of SARS-CoV, the use of ribavirin as a monotherapy was" exact="limited" post="as it required high concentration to inhibit viral replication,"/>
 <result pre="monotherapy was limited as it required high concentration to inhibit" exact="viral" post="replication, and ribavirin usage was associated with dose-dependent haemolysis"/>
 <result pre="to lopinavirâ€&quot;ritonavir alone in alleviating symptoms, shortening the duration of" exact="viral" post="shedding and hospital stay in patients with mild-to-moderate COVID-19.67"/>
 <result pre="Chloroquine and hydroxychloroquine are widely used for the treatment of" exact="malaria" post="and certain autoimmune diseases. These drugs have an established"/>
 <result pre="are widely used for the treatment of malaria and certain" exact="autoimmune diseases." post="These drugs have an established safety profile and are"/>
 <result pre="SARS-CoV-2 in vitro. Their potential mechanisms of action include blocking" exact="viral" post="entry into cells by inhibiting glycosylation of host receptors,"/>
 <result pre="entry into cells by inhibiting glycosylation of host receptors, reducing" exact="viral" post="replication, and blocking the export of newly constructed virions.45,69"/>
 <result pre="showed that chloroquine was better able to inhibit exacerbation of" exact="pneumonia" post="and improve lung imaging findings compared to the control"/>
 <result pre="clinical trial showed patients given daily hydroxychloroquine had significantly reduced" exact="viral" post="load measured by nasopharyngeal swab on day 6.5 However,"/>
 <result pre="reported the use of corticosteroids in early stages of SARS" exact="infection" post="increased the viral load.79 Furthermore, studies on the use"/>
 <result pre="of corticosteroids in early stages of SARS infection increased the" exact="viral" post="load.79 Furthermore, studies on the use of corticosteroids as"/>
 <result pre="the use of corticosteroids as an adjuvant therapy against MERS-CoV" exact="infection" post="were unable to prove efficacy because all patients died.80"/>
 <result pre="physicians and local clinical experience during the SARS epidemic, a" exact="short" post="course of corticosteroids at a low-to-moderate dose is probably"/>
 <result pre="the autoinflammatory cytokine activation syndrome. Reported side effects such as" exact="osteonecrosis" post="are concerning, but data are still conflicting and recent"/>
 <result pre="prolong or worsen the disease, and were found to prolong" exact="viral" post="shedding in MERS and SARS. Based on the current"/>
 <result pre="evidence, corticosteroids may be justified for certain medical indications (i.e." exact="acute" post="respiratory distress syndrome and sepsis) at the discretion of"/>
 <result pre="corticosteroids may be justified for certain medical indications (i.e. acute" exact="respiratory" post="distress syndrome and sepsis) at the discretion of the"/>
 <result pre="be justified for certain medical indications (i.e. acute respiratory distress" exact="syndrome" post="and sepsis) at the discretion of the physician in"/>
 <result pre="option. An observational study during the SARS epidemic showed a" exact="lower" post="mortality rate in those receiving convalescent plasma as a"/>
 <result pre="Chinese Medicine, tocilizumab can be used in patients with extensive" exact="pulmonary" post="lesions and in patients with increased IL-6 levels.66 Clinical"/>
 <result pre="a coadjuvant therapy in the early stage of the SARS" exact="infection" post="epidemic was reported to increase oxyhaemoglobin arterial saturation.95 A"/>
 <result pre="patients could improve symptoms, quality of life, and absorption of" exact="pulmonary" post="infiltration, as well as decrease the corticosteroid usage.96 Specific"/>
 <result pre="patients and was recommended for different stages and severity of" exact="disease" post="(Table 2).66 However, the effectiveness of TCM in treating"/>
 <result pre="increased oxygen index, decreased symptoms of nausea and vomiting, and" exact="lower" post="cytokine levels.101 However, we cannot draw any definitive conclusions"/>
 <result pre="SARS and H1N1 influenza.107 The use of TCM to prevent" exact="infectious disease" post="epidemics has also been described in the ancient Chinese"/>
 <result pre="and H1N1 influenza.107 The use of TCM to prevent infectious" exact="disease" post="epidemics has also been described in the ancient Chinese"/>
 <result pre="principles of TCM are to tonify qi to protect from" exact="external" post="pathogens, disperse wind and discharge heat, and resolve dampness."/>
 <result pre="are similar in nature and have defined clinical presentations. The" exact="lower" post="prevalence of coronavirus diseases in children might be accounted"/>
 <result pre="coronavirus diseases in children might be accounted for by the" exact="lower" post="exposure and relatively mild clinical presentation in the paediatric"/>
 <result pre="overlooked and therefore go undiagnosed. Comparing the immunopathology of SARS-CoV-2" exact="infection" post="between children and adults could reveal the pathology of"/>
 <result pre="between children and adults could reveal the pathology of the" exact="disease" post="and might lead to possible treatment strategies for â€˜recurrentâ€™"/>
 <result pre="have started since the beginning of the epidemic is nothing" exact="short" post="of impressive. Combining advanced technologies in the field of"/>
 <result pre="Building, Lee High Road, London, England, SE13 5PT. BioExcel Publishing" exact="Limited" post="is registered in England Number 10038393. VAT GB 252"/>
 <result pre="References 1HonKLiAChengFLeungTNgPPersonal view of SARS: confusing definition, confusing diagnosesLancet200336193731984198510.1016/S0140-6736(03)13556-812801758 2HonKLSevere" exact="respiratory" post="syndromes: travel history mattersTravel Med Infect Dis201311528528723820509 3HonKLJust like"/>
 <result pre="like SARSPediatr Pulmonol200944101048104910.1002/ppul.2108519774678 4collab: World Health OrganizationClinical management of severe" exact="acute" post="respiratory infection when COVID-19 is suspectedhttps://www.who.int/publications-detail/clinical-management-of-severe-acute-respiratory-infection-when-novel-coronavirus-(ncov)-infection-is-suspected. Published 2020Accessed April"/>
 <result pre="SARSPediatr Pulmonol200944101048104910.1002/ppul.2108519774678 4collab: World Health OrganizationClinical management of severe acute" exact="respiratory" post="infection when COVID-19 is suspectedhttps://www.who.int/publications-detail/clinical-management-of-severe-acute-respiratory-infection-when-novel-coronavirus-(ncov)-infection-is-suspected. Published 2020Accessed April 16,"/>
 <result pre="Pulmonol200944101048104910.1002/ppul.2108519774678 4collab: World Health OrganizationClinical management of severe acute respiratory" exact="infection" post="when COVID-19 is suspectedhttps://www.who.int/publications-detail/clinical-management-of-severe-acute-respiratory-infection-when-novel-coronavirus-(ncov)-infection-is-suspected. Published 2020Accessed April 16, 2020"/>
 <result pre="2020 5ShenKYangYWangTet al.Diagnosis, treatment, and prevention of 2019 novel coronavirus" exact="infection" post="in children: expertsâ€™ consensus statementWorld J Pediatr202010.1007/s12519-020-00343-7 6collab: World"/>
 <result pre="epidemic in Hong KongJ Epidemiol Community Health200357965265410.1136/jech.57.9.65212933765 9ChengVCCChanJFWToKKWYuenKYClinical management and" exact="infection" post="control of SARS: lessons learnedAntiviral Res2013100240741910.1016/j.antiviral.2013.08.01623994190 10ChengVCCTangBSFWuAKLChuCMYuenKYMedical treatment of"/>
 <result pre="infection control of SARS: lessons learnedAntiviral Res2013100240741910.1016/j.antiviral.2013.08.01623994190 10ChengVCCTangBSFWuAKLChuCMYuenKYMedical treatment of" exact="viral pneumonia" post="including SARS in immunocompetent adultJ Infect200449426227310.1016/j.jinf.2004.07.01015474623 11ChuCMChengVCCHungIFNet al.Role of"/>
 <result pre="control of SARS: lessons learnedAntiviral Res2013100240741910.1016/j.antiviral.2013.08.01623994190 10ChengVCCTangBSFWuAKLChuCMYuenKYMedical treatment of viral" exact="pneumonia" post="including SARS in immunocompetent adultJ Infect200449426227310.1016/j.jinf.2004.07.01015474623 11ChuCMChengVCCHungIFNet al.Role of"/>
 <result pre="virological and clinical findingsThorax200459325225610.1136/thorax.2003.01265814985565 12LauACYamLYSoLKManagement of critically ill patients with" exact="Severe" post="Acute Respiratory Syndrome (SARS)Int J Med Sci20121111010.7150/ijms.1.1 13collab: World"/>
 <result pre="and clinical findingsThorax200459325225610.1136/thorax.2003.01265814985565 12LauACYamLYSoLKManagement of critically ill patients with Severe" exact="Acute" post="Respiratory Syndrome (SARS)Int J Med Sci20121111010.7150/ijms.1.1 13collab: World Health"/>
 <result pre="clinical findingsThorax200459325225610.1136/thorax.2003.01265814985565 12LauACYamLYSoLKManagement of critically ill patients with Severe Acute" exact="Respiratory" post="Syndrome (SARS)Int J Med Sci20121111010.7150/ijms.1.1 13collab: World Health OrganizationMERS"/>
 <result pre="findingsThorax200459325225610.1136/thorax.2003.01265814985565 12LauACYamLYSoLKManagement of critically ill patients with Severe Acute Respiratory" exact="Syndrome" post="(SARS)Int J Med Sci20121111010.7150/ijms.1.1 13collab: World Health OrganizationMERS situation"/>
 <result pre="update, January 2020http://www.emro.who.int/pandemic-epidemic-diseases/mers-cov/mers-situation-update-january-2020.html. Published 2020Accessed April 13, 2020 14ZumlaAHuiDSPerlmanSMiddle East" exact="respiratory" post="syndromeLancet20152569997995100710.1016/S0140-6736(15)60454-8 15MomattinHAl-AliAYAl-TawfiqJAA systematic review of therapeutic agents for the"/>
 <result pre="of therapeutic agents for the treatment of the Middle East" exact="Respiratory" post="Syndrome Coronavirus (MERS-CoV)Travel Med Infect Dis20193091810.1016/j.tmaid.2019.06.01231252170 16ArabiYMAsiriAYAssiriAMet al.Treatment of"/>
 <result pre="therapeutic agents for the treatment of the Middle East Respiratory" exact="Syndrome" post="Coronavirus (MERS-CoV)Travel Med Infect Dis20193091810.1016/j.tmaid.2019.06.01231252170 16ArabiYMAsiriAYAssiriAMet al.Treatment of Middle"/>
 <result pre="Coronavirus (MERS-CoV)Travel Med Infect Dis20193091810.1016/j.tmaid.2019.06.01231252170 16ArabiYMAsiriAYAssiriAMet al.Treatment of Middle East" exact="respiratory" post="syndrome with a combination of lopinavir/ritonavir and interferon-Î²1b (MIRACLE"/>
 <result pre="(MERS-CoV)Travel Med Infect Dis20193091810.1016/j.tmaid.2019.06.01231252170 16ArabiYMAsiriAYAssiriAMet al.Treatment of Middle East respiratory" exact="syndrome" post="with a combination of lopinavir/ritonavir and interferon-Î²1b (MIRACLE trial):"/>
 <result pre="sequential randomized controlled trialTrials2020211810.1186/s13063-019-3846-x31900204 17collab: US National Library of MedicineMERS-CoV" exact="Infection" post="tReated with A Combination of Lopinavir/Ritonavir and Interferon Beta-1b"/>
 <result pre="2020 18YongCYOngHKYeapSKHoKLTanWSRecent advances in the vaccine development against Middle East" exact="respiratory" post="syndrome-coronavirusFront Microbiol201910August11810.3389/fmicb.2019.0178130728808 19HonKLLeungKKSevere acute respiratory symptoms and suspected SARS"/>
 <result pre="the vaccine development against Middle East respiratory syndrome-coronavirusFront Microbiol201910August11810.3389/fmicb.2019.0178130728808 19HonKLLeungKKSevere" exact="acute" post="respiratory symptoms and suspected SARS again 2020Hong Kong Med"/>
 <result pre="vaccine development against Middle East respiratory syndrome-coronavirusFront Microbiol201910August11810.3389/fmicb.2019.0178130728808 19HonKLLeungKKSevere acute" exact="respiratory" post="symptoms and suspected SARS again 2020Hong Kong Med J2020261787910.12809/hkmj20837532077866"/>
 <result pre="and Treatment Coronavirus (COVID-19)StatPearls Publishing2020http://www.ncbi.nlm.nih.gov/pubmed/32150360Accessed April 15, 2020 24ZhouPYangXLouWangXGet al.A" exact="pneumonia" post="outbreak associated with a new coronavirus of probable bat"/>
 <result pre="in Wuhan, ChinaLancet20203951022349750610.1016/S0140-6736(20)30183-531986264 26XuZShiLWangYet al.Pathological findings of COVID-19 associated with" exact="acute" post="respiratory distress syndromeLancet Respir Med20208442042210.1016/S2213-2600(20)30076-X32085846 27DingYWangHShenHet al.The clinical pathology"/>
 <result pre="Wuhan, ChinaLancet20203951022349750610.1016/S0140-6736(20)30183-531986264 26XuZShiLWangYet al.Pathological findings of COVID-19 associated with acute" exact="respiratory" post="distress syndromeLancet Respir Med20208442042210.1016/S2213-2600(20)30076-X32085846 27DingYWangHShenHet al.The clinical pathology of"/>
 <result pre="distress syndromeLancet Respir Med20208442042210.1016/S2213-2600(20)30076-X32085846 27DingYWangHShenHet al.The clinical pathology of severe" exact="acute" post="respiratory syndrome (SARS): a report from ChinaJ Pathol2003200328228910.1002/path.144012845623 28NgDLAl"/>
 <result pre="syndromeLancet Respir Med20208442042210.1016/S2213-2600(20)30076-X32085846 27DingYWangHShenHet al.The clinical pathology of severe acute" exact="respiratory" post="syndrome (SARS): a report from ChinaJ Pathol2003200328228910.1002/path.144012845623 28NgDLAl HosaniFKeatingMKet"/>
 <result pre="Respir Med20208442042210.1016/S2213-2600(20)30076-X32085846 27DingYWangHShenHet al.The clinical pathology of severe acute respiratory" exact="syndrome" post="(SARS): a report from ChinaJ Pathol2003200328228910.1002/path.144012845623 28NgDLAl HosaniFKeatingMKet al.Clinicopathologic,"/>
 <result pre="and ultrastructural findings of a fatal case of middle east" exact="respiratory" post="syndrome coronavirus infection in the United Arab Emirates, April"/>
 <result pre="ultrastructural findings of a fatal case of middle east respiratory" exact="syndrome" post="coronavirus infection in the United Arab Emirates, April 2014Am"/>
 <result pre="of a fatal case of middle east respiratory syndrome coronavirus" exact="infection" post="in the United Arab Emirates, April 2014Am J Pathol2016186365265810.1016/j.ajpath.2015.10.02426857507"/>
 <result pre="2014Am J Pathol2016186365265810.1016/j.ajpath.2015.10.02426857507 29HonKMERS = SARS?Hong Kong Med J201521547810.12809/hkmj15462626493082 30HuiDSMemishZAZumlaASevere" exact="acute" post="respiratory syndrome vs. The Middle East respiratory syndromeCurr Opin"/>
 <result pre="J Pathol2016186365265810.1016/j.ajpath.2015.10.02426857507 29HonKMERS = SARS?Hong Kong Med J201521547810.12809/hkmj15462626493082 30HuiDSMemishZAZumlaASevere acute" exact="respiratory" post="syndrome vs. The Middle East respiratory syndromeCurr Opin Pulm"/>
 <result pre="Pathol2016186365265810.1016/j.ajpath.2015.10.02426857507 29HonKMERS = SARS?Hong Kong Med J201521547810.12809/hkmj15462626493082 30HuiDSMemishZAZumlaASevere acute respiratory" exact="syndrome" post="vs. The Middle East respiratory syndromeCurr Opin Pulm Med201420323324110.1097/MCP.000000000000004624626235"/>
 <result pre="Med J201521547810.12809/hkmj15462626493082 30HuiDSMemishZAZumlaASevere acute respiratory syndrome vs. The Middle East" exact="respiratory" post="syndromeCurr Opin Pulm Med201420323324110.1097/MCP.000000000000004624626235 31LiAHonKChengWet al.Severe acute respiratory syndrome:"/>
 <result pre="The Middle East respiratory syndromeCurr Opin Pulm Med201420323324110.1097/MCP.000000000000004624626235 31LiAHonKChengWet al.Severe" exact="acute" post="respiratory syndrome: â€œSARSâ€� or â€œnot SARS.â€�J Paediatr Child Health2004401â€&quot;2636510.1111/j.1440-1754.2004.00294.x14718009"/>
 <result pre="Middle East respiratory syndromeCurr Opin Pulm Med201420323324110.1097/MCP.000000000000004624626235 31LiAHonKChengWet al.Severe acute" exact="respiratory" post="syndrome: â€œSARSâ€� or â€œnot SARS.â€�J Paediatr Child Health2004401â€&quot;2636510.1111/j.1440-1754.2004.00294.x14718009 32HonKLLeungASYCheungKLet"/>
 <result pre="â€œSARSâ€� or â€œnot SARS.â€�J Paediatr Child Health2004401â€&quot;2636510.1111/j.1440-1754.2004.00294.x14718009 32HonKLLeungASYCheungKLet al.Typical or" exact="atypical pneumonia" post="and severe acute respiratory symptoms in PICUClin Respir J20159336637110.1111/crj.1214924720856"/>
 <result pre="or â€œnot SARS.â€�J Paediatr Child Health2004401â€&quot;2636510.1111/j.1440-1754.2004.00294.x14718009 32HonKLLeungASYCheungKLet al.Typical or atypical" exact="pneumonia" post="and severe acute respiratory symptoms in PICUClin Respir J20159336637110.1111/crj.1214924720856"/>
 <result pre="Paediatr Child Health2004401â€&quot;2636510.1111/j.1440-1754.2004.00294.x14718009 32HonKLLeungASYCheungKLet al.Typical or atypical pneumonia and severe" exact="acute" post="respiratory symptoms in PICUClin Respir J20159336637110.1111/crj.1214924720856 33TaiWHeLZhangXet al.Characterization of"/>
 <result pre="Child Health2004401â€&quot;2636510.1111/j.1440-1754.2004.00294.x14718009 32HonKLLeungASYCheungKLet al.Typical or atypical pneumonia and severe acute" exact="respiratory" post="symptoms in PICUClin Respir J20159336637110.1111/crj.1214924720856 33TaiWHeLZhangXet al.Characterization of the"/>
 <result pre="novel coronavirus: implication for development of RBD protein as a" exact="viral" post="attachment inhibitor and vaccineCell Mol Immunol20201810.1038/s41423-020-0400-431611651 34WrappDWangNCorbettKSet al.Cryo-EM structure"/>
 <result pre="April 16, 2020 37collab: World Health OrganizationReport of the WHO-China" exact="Joint" post="Mission on Coronavirus Disease 2019 (COVID-19)https://www.who.int/docs/default-source/coronaviruse/who-china-joint-mission-on-covid-19-final-report.pdf. Published 2002Accessed April"/>
 <result pre="World Health OrganizationReport of the WHO-China Joint Mission on Coronavirus" exact="Disease" post="2019 (COVID-19)https://www.who.int/docs/default-source/coronaviruse/who-china-joint-mission-on-covid-19-final-report.pdf. Published 2002Accessed April 16, 2020 38collab: World"/>
 <result pre="the diagnosis and treatment of 2019 novel coronavirus (2019-nCoV) infected" exact="pneumonia" post="(standard version)Mil Med Res20207110.1186/s40779-020-0233-6 41PhuaJWengLLingLet al.Intensive care management of"/>
 <result pre="(standard version)Mil Med Res20207110.1186/s40779-020-0233-6 41PhuaJWengLLingLet al.Intensive care management of coronavirus" exact="disease" post="2019 (COVID-19 ): challenges and recommendationsLancet Respir202020192011210.1016/S2213-2600(20)30161-2 42GreinJOhmagariNShinDet al.Compassionate"/>
 <result pre="a direct-acting antiviral that inhibits RNA-dependent RNA polymerase from severe" exact="acute" post="respiratory syndrome coronavirus 2 with high potencyJ Biol Chem202012610.1074/jbc.RA120.01367931649031"/>
 <result pre="direct-acting antiviral that inhibits RNA-dependent RNA polymerase from severe acute" exact="respiratory" post="syndrome coronavirus 2 with high potencyJ Biol Chem202012610.1074/jbc.RA120.01367931649031 47WangYZhangDDuGet"/>
 <result pre="antiviral that inhibits RNA-dependent RNA polymerase from severe acute respiratory" exact="syndrome" post="coronavirus 2 with high potencyJ Biol Chem202012610.1074/jbc.RA120.01367931649031 47WangYZhangDDuGet al.Remdesivir"/>
 <result pre="double-blind, placebo-controlled, multicentre trialLancet2020395102361569157810.1016/S0140-6736(20)31022-932423584 48collab: National Institute of Allergy and" exact="Infectious" post="DiseaseNIH clinical trial shows remdesivir accelerates recovery from advanced"/>
 <result pre="antiviral activity of remdesivir (GS-5734TM) in participants with moderate coronavirus" exact="disease" post="(COVID-19) compared to standard of care treatmenthttps://clinicaltrials.gov/ct2/show/NCT04292730. Published 2020Accessed"/>
 <result pre="antiviral activity of remdesivir (GS-5734TM) in participants with severe coronavirus" exact="disease" post="(COVID-19)https://clinicaltrials.gov/ct2/show/NCT04292899. Published 2020Accessed April 16, 2020 52collab: US National"/>
 <result pre="safety of Xiyanping injection in the treatment of new coronavirus" exact="infection" post="pneumonia (General and Severe)https://clinicaltrials.gov/ct2/show/NCT04295551Accessed April 22, 2020 58collab: US"/>
 <result pre="of Xiyanping injection in the treatment of new coronavirus infection" exact="pneumonia" post="(General and Severe)https://clinicaltrials.gov/ct2/show/NCT04295551Accessed April 22, 2020 58collab: US National"/>
 <result pre="(DIC)https://clinicaltrials.gov/ct2/show/NCT04343768?term=lopinavir&amp;amp;cond=Covid+19&amp;amp;draw=3&amp;amp;rank=15. Published 2020Accessed April 22, 2020 59ChanKSLaiSTChuCMet al.Treatment of severe" exact="acute" post="respiratory syndrome with lopinavir/ritonavir: a multicentre retrospective matched cohort"/>
 <result pre="Published 2020Accessed April 22, 2020 59ChanKSLaiSTChuCMet al.Treatment of severe acute" exact="respiratory" post="syndrome with lopinavir/ritonavir: a multicentre retrospective matched cohort studyHong"/>
 <result pre="2020Accessed April 22, 2020 59ChanKSLaiSTChuCMet al.Treatment of severe acute respiratory" exact="syndrome" post="with lopinavir/ritonavir: a multicentre retrospective matched cohort studyHong Kong"/>
 <result pre="cohort studyHong Kong Med J20039639940614660806 60ArabiYMAlothmanABalkhyHHet al.Treatment of Middle East" exact="Respiratory" post="Syndrome with a combination of lopinavir-ritonavir and interferon-Î²1b (MIRACLE"/>
 <result pre="studyHong Kong Med J20039639940614660806 60ArabiYMAlothmanABalkhyHHet al.Treatment of Middle East Respiratory" exact="Syndrome" post="with a combination of lopinavir-ritonavir and interferon-Î²1b (MIRACLE trial):"/>
 <result pre="SARS in the Greater Toronto areaJAMA200328921280110.1001/jama.289.21.JOC3088512734147 64SandersJMMonogueMLJodlowskiTZCutrellJBPharmacologic treatments for coronavirus" exact="disease" post="2019 (COVID-19): a reviewJama2020323181824183610.1001/jama.2020.6019 65FalzaranoDde WitEMartellaroCCallisonJMunsterVJFeldmannHInhibition of novel Î²"/>
 <result pre="phosphate has shown apparent efficacy in treatment of COVID-19 associated" exact="pneumonia" post="in clinical studiesBiosci Trends2020141727310.5582/bst.2020.0104732074550 71GautretPLagierJ-CParolaPet al.Hydroxychloroquine and azithromycin as"/>
 <result pre="different dosages as adjunctive therapy of hospitalized patients with severe" exact="respiratory" post="syndrome in the context of coronavirus (SARS-CoV-2) infection: preliminary"/>
 <result pre="dosages as adjunctive therapy of hospitalized patients with severe respiratory" exact="syndrome" post="in the context of coronavirus (SARS-CoV-2) infection: preliminary safety"/>
 <result pre="early corticosteroid treatment on plasma SARS-associated coronavirus RNA concentrations in" exact="adult" post="patientsJ Clin Virol200431430430910.1016/j.jcv.2004.07.00615494274 80Al-TawfiqJAMemishZAUpdate on therapeutic options for Middle"/>
 <result pre="patientsJ Clin Virol200431430430910.1016/j.jcv.2004.07.00615494274 80Al-TawfiqJAMemishZAUpdate on therapeutic options for Middle East" exact="Respiratory" post="Syndrome Coronavirus (MERS-CoV)Expert Rev Anti Infect Ther201715326927510.1080/14787210.2017.127171227937060 81ZhaoJPHuYDuRHet al.Expert"/>
 <result pre="Clin Virol200431430430910.1016/j.jcv.2004.07.00615494274 80Al-TawfiqJAMemishZAUpdate on therapeutic options for Middle East Respiratory" exact="Syndrome" post="Coronavirus (MERS-CoV)Expert Rev Anti Infect Ther201715326927510.1080/14787210.2017.127171227937060 81ZhaoJPHuYDuRHet al.Expert Consensus"/>
 <result pre="83KoJ-HSeokHChoSYet al.Challenges of convalescent plasma infusion therapy in Middle East" exact="respiratory" post="coronavirus infection: a single centre experienceAntivir Ther201823761762210.3851/IMP324329923831 84CasadevallAPirofskiLThe convalescent"/>
 <result pre="and functional exhaustion of T cells in patients with coronavirus" exact="disease" post="2019 (COVID-19)medRxiv2202010.1101/2020.02.18.20024364 92XuXHanMLiTet al.Effective treatment of severe COVID-19 patients"/>
 <result pre="Sci USA202011720109701097510.1073/pnas.200561511732350134 93collab: US National Library of MedicineTocilizumab in COVID-19" exact="pneumonia" post="(TOCIVID-19) (TOCIVID-19)https://clinicaltrials.gov/ct2/show/NCT04317092. Published 2020Accessed April 17, 2020 94collab: Chinese"/>
 <result pre="RegistryFavipiravir combined with tocilizumab in the treatment of novel coronavirus" exact="pneumonia" post="(COVID-19 ) - a multicenter, randomized, controlled trialhttp://www.chictr.org.cn/showprojen.aspx?proj=51126. Published"/>
 <result pre="Published 2020Accessed April 17, 2020 95LuoYWangCZHesse-FongJLinJGYuanCSApplication of Chinese medicine in" exact="acute" post="and critical medical conditionsAm J Chin Med20194761223123510.1142/S0192415X1950062931505937 96LiuXZhangMHeLLiYChinese herbs"/>
 <result pre="Chin Med20194761223123510.1142/S0192415X1950062931505937 96LiuXZhangMHeLLiYChinese herbs combined with Western medicine for severe" exact="acute" post="respiratory syndrome (SARS)Cochrane Database Syst Rev201210.1002/14651858.cd004882.pub3 97CinatlJMorgensternBBauerGChandraPRabenauHDoerrHWGlycyrrhizin, an active"/>
 <result pre="Med20194761223123510.1142/S0192415X1950062931505937 96LiuXZhangMHeLLiYChinese herbs combined with Western medicine for severe acute" exact="respiratory" post="syndrome (SARS)Cochrane Database Syst Rev201210.1002/14651858.cd004882.pub3 97CinatlJMorgensternBBauerGChandraPRabenauHDoerrHWGlycyrrhizin, an active component"/>
 <result pre="96LiuXZhangMHeLLiYChinese herbs combined with Western medicine for severe acute respiratory" exact="syndrome" post="(SARS)Cochrane Database Syst Rev201210.1002/14651858.cd004882.pub3 97CinatlJMorgensternBBauerGChandraPRabenauHDoerrHWGlycyrrhizin, an active component of"/>
 <result pre="al.Can Chinese medicine be used for prevention of corona virus" exact="disease" post="2019 (COVID-19)? A review of historical classics, research evidence"/>
 <result pre="MedicineOutcomes related to COVID-19 treated with hydroxychloroquine among in-patients with" exact="symptomatic" post="diseasehttps://clinicaltrials.gov/ct2/show/NCT04332991. Published 2020Accessed April 19, 2020 114collab: US National"/>
 <result pre="National Library of MedicineThe impact of camostat mesilate on COVID-19" exact="infection" post="(CamoCO-19)https://clinicaltrials.gov/ct2/show/NCT04321096?term=camostat+mesilate&amp;amp;cond=COVID&amp;amp;draw=2&amp;amp;rank=4. Published 2020Accessed April 22, 2020 115collab: US National"/>
 <result pre="effects of nucleoside and nucleotide drugs used for treatment of" exact="chronic hepatitis" post="BCurr Hepat Rep201092759010.1007/s11901-010-0039-120461127 118Lexicomp OnlineFavipiravir (United States: Not Commercially"/>
 <result pre="of nucleoside and nucleotide drugs used for treatment of chronic" exact="hepatitis" post="BCurr Hepat Rep201092759010.1007/s11901-010-0039-120461127 118Lexicomp OnlineFavipiravir (United States: Not Commercially"/>
 <result pre="of MedicineGlucocorticoid therapy for COVID-19 critically ill patients with severe" exact="acute" post="espiratory failurehttps://clinicaltrials.gov/ct2/show/NCT04244591. Published 2020Accessed April 18, 2020 121collab: University"/>
 <result pre="2020 122HonKLLeungKKYLeungAKCet al.Overview: the history and pediatric perspectives of severe" exact="acute" post="respiratory syndromes: novel or just like SARSPediatr Pulmonol202010.1002/ppul.24810 Table"/>
 <result pre="122HonKLLeungKKYLeungAKCet al.Overview: the history and pediatric perspectives of severe acute" exact="respiratory" post="syndromes: novel or just like SARSPediatr Pulmonol202010.1002/ppul.24810 Table 1"/>
 <result pre="by 100 mg IV once-daily maintenance doses for 9 days" exact="Increased" post="hepatic enzymesDiarrhoeaRashRenal impairmentHypotension Lopinavirâ€&quot;ritonavir (protease inhibitor)54,56,59,66,110,112 Adult: 500 mg"/>
 <result pre="&amp;amp; State Administration of Traditional Chinese Medicine.66 Stage of COVID-19" exact="disease" post="and symptoms Recommended formulation Before diagnosis Fatigue and gastrointestinal"/>
 <result pre="disease and symptoms Recommended formulation Before diagnosis Fatigue and gastrointestinal" exact="discomfort" post="Huoxiang Zhengqi capsules Fatigue and fever Jinhua Qinggan granulesLianhua"/>
 <result pre="Treatment period (confirmed case) Mild Cold dampness and stagnation lung" exact="syndrome" post="Raw ephedra 6 g, raw gypsum 15 g, almond"/>
 <result pre="fruit 9 g, ginger 15 g. Dampness and heat-accumulation lung" exact="syndrome" post="Betel nut 10 g, apple 10 g, Magnolia 10"/>
 <result pre="g, raw licorice 5 g. Moderate Dampness and stagnation lung" exact="syndrome" post="Raw ephedra 6 g, bitter almond 15 g, raw"/>
 <result pre="red 15 g, raw licorice 10 g. Cold dampness lung" exact="syndrome" post="Atractylodes lancea 15 g, Chenpi 10 g, Magnolia 10"/>
 <result pre="Zhihuo 10 g, ginger 10 g, betel nut 10 g." exact="Severe" post="Plague poison and lung-closing syndrome Raw ephedra 6 g,"/>
 <result pre="10 g, ginger 10 g, betel nut 10 g. Severe" exact="Plague" post="poison and lung-closing syndrome Raw ephedra 6 g, almond"/>
 <result pre="g, betel nut 10 g. Severe Plague poison and lung-closing" exact="syndrome" post="Raw ephedra 6 g, almond 9 g, raw gypsum"/>
 <result pre="Root 10 g, gardenia 10 g, red peony 10 g." exact="Syndrome" post="of flaring heat in qifen and yingfen Gypsum (fried"/>
 <result pre="gardenia 15 g, raw licorice 6 g. Stage of COVID-19" exact="disease" post="and symptoms Treatment period Critical case Syndrome of inner"/>
 <result pre="Stage of COVID-19 disease and symptoms Treatment period Critical case" exact="Syndrome" post="of inner blocking causing collapse Ginseng 15 g, Heishun"/>
 <result pre="symptoms Treatment period Critical case Syndrome of inner blocking causing" exact="collapse" post="Ginseng 15 g, Heishun tablets (decoct first) 10 g,"/>
 <result pre="15 g, delivered with Suhexiang pill or Angong Niuhuang pill." exact="Viral" post="infection or combined mild bacterial infection Xiyanping injection 100"/>
 <result pre="g, delivered with Suhexiang pill or Angong Niuhuang pill. Viral" exact="infection" post="or combined mild bacterial infection Xiyanping injection 100 mg"/>
 <result pre="pill or Angong Niuhuang pill. Viral infection or combined mild" exact="bacterial infection" post="Xiyanping injection 100 mg bid High fever with disturbance"/>
 <result pre="or Angong Niuhuang pill. Viral infection or combined mild bacterial" exact="infection" post="Xiyanping injection 100 mg bid High fever with disturbance"/>
 <result pre="fever with disturbance of consciousness Xingnaojing injection 20 mL bid" exact="Systemic" post="inflammatory response syndrome or/and multiple organ failure Xuebijing injection"/>
 <result pre="of consciousness Xingnaojing injection 20 mL bid Systemic inflammatory response" exact="syndrome" post="or/and multiple organ failure Xuebijing injection 100 mL Immunosuppression"/>
 <result pre="Xuebijing injection 100 mL Immunosuppression Shenmai injection 100 mL bid" exact="Shock" post="Shenfu injection bid Stage of COVID-19 disease and symptoms"/>
 <result pre="100 mL bid Shock Shenfu injection bid Stage of COVID-19" exact="disease" post="and symptoms Rehabilitation period Lung and spleen qi deficiency"/>
 <result pre="COVID-19 disease and symptoms Rehabilitation period Lung and spleen qi" exact="deficiency" post="syndrome French Pinellia 9 g, Chenpi 10 g, Codonopsis"/>
 <result pre="disease and symptoms Rehabilitation period Lung and spleen qi deficiency" exact="syndrome" post="French Pinellia 9 g, Chenpi 10 g, Codonopsis 15"/>
 <result pre="villosum 6 g, and Licorice 6 g Qi and Yin" exact="deficiency" post="syndrome North and south radix salviae 10 g, ophiopogonis"/>
 <result pre="6 g, and Licorice 6 g Qi and Yin deficiency" exact="syndrome" post="North and south radix salviae 10 g, ophiopogonis 15"/>
 <result pre="North and south radix salviae 10 g, ophiopogonis 15 g," exact="American" post="ginseng 6 g, schisandra 6 g, gypsum 15 g,"/>
 <result pre="version of the Diagnosis and Treatment Protocol for Novel Coronavirus" exact="Pneumonia" post="released by the National Health Commission &amp;amp; State Administration"/>
</results>
